HB 1380·MD·house
Health Insurance - Prescriptions for Gender-Affirming Care and Hormone Therapy - Coverage and Dispensing Requirements
FailedFiled Feb 13, 2026
Sponsor: Fair
Latest Action
Hearing 3/13 at 1:30 p.m. (House)
Mar 13, 2026
Summary
The bill mandates that insurers, nonprofit health plans, and HMOs in Maryland cover a single dispensing of qualifying gender‑affirming or hormone‑therapy drugs for up to 12 months. It also changes pharmacy rules so that, after Jan. 1 2027, such prescriptions may be dispensed in a 12‑month supply rather than the current 90‑day limit, with certain exceptions. The measure is intended to improve access to these medications.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HB 1380 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 1380 freeOr ask your AI assistant about HB 1380 directly:
Add to Claude, ChatGPT or Cursor